Arcus Biosciences Inc
(RCUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,000 | -4,000 | -307,000 | -226,000 | -155,000 |
| Depreciation Amortization | -8,000 | -3,000 | -11,000 | -8,000 | -4,000 |
| Accounts receivable | 20,000 | 13,000 | 15,000 | 15,000 | 4,000 |
| Accounts payable and accrued liabilities | -1,000 | -1,000 | -1,000 | -3,000 | -9,000 |
| Other Working Capital | -56,000 | -37,000 | -71,000 | -47,000 | -37,000 |
| Other Operating Activity | 46,000 | 30,000 | 69,000 | 51,000 | 46,000 |
| Operating Cash Flow | $-96,000 | $-2,000 | $-306,000 | $-218,000 | $-155,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -109,000 | -165,000 | 194,000 | 164,000 | 149,000 |
| PPE Investments | -4,000 | -4,000 | -24,000 | -18,000 | -8,000 |
| Sale Of Investment | 7,000 | 0 | 24,000 | 20,000 | 14,000 |
| Investing Cash Flow | $-106,000 | $-169,000 | $194,000 | $166,000 | $155,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 232,000 | 229,000 | 33,000 | 30,000 | 24,000 |
| Other Financing Activity | -1,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $231,000 | $229,000 | $33,000 | $30,000 | $24,000 |
| Beginning Cash Position | 130,000 | 130,000 | 209,000 | 209,000 | 209,000 |
| End Cash Position | 159,000 | 188,000 | 130,000 | 187,000 | 233,000 |
| Net Cash Flow | $29,000 | $58,000 | $-79,000 | $-22,000 | $24,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -96,000 | -2,000 | -306,000 | -218,000 | -155,000 |
| Capital Expenditure | -4,000 | -4,000 | -24,000 | -18,000 | -8,000 |
| Free Cash Flow | -100,000 | -6,000 | -330,000 | -236,000 | -163,000 |